|
Inside This Week's Issue
Dear Colleagues:
I am pleased to present this week's NCI Cancer Bulletin.
Our lead story describes the Progress for Patients Award Program, a partnership between NCI and the Avon Foundation that is providing more than $7 million to support breast cancer research this year. The Director's Update by NCI Deputy Director Dr. Karen Antman discusses the importance of NCI's translational research initiatives. Other articles of interest include:
- A spotlight on NCI's recent grant to support nanotechnology research at Emory University and other institutions in Georgia
- A research study on breast density and mammography sensitivity
- A study on a drug combination that improves outcomes in advanced prostate cancer
- A clinical trial using immunotherapy to treat metastatic melanoma
I hope you will find this issue of the NCI Cancer Bulletin interesting and informative.
Sincerely,
Andrew C. von Eschenbach, M.D.
Director, National Cancer Institute
|
|
Download Current Issue
View Previous Issues
|
|